Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Lenvatinib 18 / Everolimus 5, Renal Cell Carcinoma, second line

Protocol-ID: 850 V1.0 (Mini), LENV18/EVER5, RCC, second line

Indication(s)

  • Renal Cell Carcinoma; ICD-10 C64
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 25.01.2017